First-dose effects of fingolimod: Pooled safety data from three phase 3 studies

References

Page 1

	Year	Citations
WORLD MEDICAL ASSOCIATION DECLARATION OF HELSINKI: Ethical Principles for Medical Research Involving Human Subjects Journal of obstetrics and gynaecology research Medical EthicsBiomedical EthicGlobal HealthInformed ConsentInternational Health	2001	3.5K
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor, New England Journal of Medicine	2010	2.6K
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung, New England Journal of Medicine	2010	2.2K
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis Ludwig Kappos, Jack P. Antel, Giancarlo Comi, New England Journal of Medicine	2006	1.1K
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial Peter A. Calabresi, Ernst-Wilhelm Radüe, Douglas S. Goodin, The Lancet Neurology Disease ManagementRelapsing-remitting Multiple SclerosisDisease ProgressionNeurological DisorderClinical Trials	2014	815
Regional and tissue specific transcript signatures of ion channel genes in the non‐diseased human heart Nathalie Gaborit, Sabrina Le Bouter, Viktória Szüts, The Journal of Physiology Cardiac MuscleHeart FailureGeneticsPurkinje FibresCardiology	2007	509
The Heart Rate Decrease Caused by Acute FTY720 Administration Is Mediated by the G Protein-Gated Potassium Channel IKACh L. Koyrakh, María I. Román, Volker Brinkmann, American Journal of Transplantation	2005	165
Circadian variation of heart rate variability Simon C. Malpas, Gordon Purdie Cardiovascular Research Vagal NeuropathySleepSleep DisorderAlertnessAutonomic System	1990	129
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study Journal of Neurology Disease ProgressionNeurological DisorderCardiovascular PharmacologyPharmacotherapyPhase 3B	2013	125
FTY720: Placebo‐Controlled Study of the Effect on Cardiac Rate and Rhythm in Healthy Subjects Robert Schmouder, Denise Serra, Yibin Wang, The Journal of Clinical Pharmacology Heart FailureHealthy SubjectsCardiovascular PharmacologyPharmacotherapyCardiac Rate	2006	110

Page 1